neuroleptic agent; adverse drug reaction; article; coronavirus disease 2019; decision support system; drug response; drug substitution; genetic variability; genetics; genomic medicine; genotyping; health care personnel; human; mental health; pandemic; patient engagement; personalized medicine; pharmacogenetic testing; pharmacogenomics; prescription; prevalence; psychiatry; psychosis; therapy; treatment outcome; treatment response